News of Note—Teva strikes labor agreement at Israeli plant

Woman typing on computer
(Max Pixel/CC0)

> Aurobindo this week reported that it has completed its €74 acquisition of generic and OTC drugs from Apotex in five European countries. The Hindu article

> Teva has completed a union agreement covering the 1,200 employees at its Kfar Saba plant in Israel that runs through 2019 and grants them a 2.2% raise. Globes artlcle

> Immunomedics, which received a CRL in January tied to its manufacturing plant in New Jersey, reported that it expects to sit down with the FDA after receiving an establishment inspection report for the facility. Filing

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> WuXi Biologics and Amicus Therapeutics have struck an exclusive commercial manufacturing partnership for Amicus' Pompe biologic ATB200. Release

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.